PyrlsApp Profile Banner
Pyrls Profile
Pyrls

@PyrlsApp

Followers
20K
Following
2K
Media
832
Statuses
2K

The @PyrlsApp makes drug information easy for 50,000+ clinicians and student clinicians 🔮 💊 | a @ycombinator company

Joined March 2021
Don't wanna be here? Send us removal request.
@PyrlsApp
Pyrls
2 years
✨ FREE 225-Question NAPLEX Practice Test!. Just create a FREE Pyrls account at (or already have one 😊). Being a PharmD grad is expensive. license fees, boards fees, test prep materials fees, interview travel, oh and STUDENT LOANS. We know, we've been
Tweet media one
6
44
137
@PyrlsApp
Pyrls
17 hours
FDA Approves ANZUPGO (delgocitinib) Cream for the Treatment of Chronic Hand Eczema (CHE)
Tweet media one
0
0
10
@PyrlsApp
Pyrls
4 days
FDA Approves SHINGRIX Prefilled Syringe
Tweet media one
0
0
4
@PyrlsApp
Pyrls
5 days
Tweet media one
0
1
25
@PyrlsApp
Pyrls
10 days
FDA Approves KIRSTY (insulin aspart-xjhz), the First Interchangeable Biosimilar to NOVOLOG
Tweet media one
0
5
13
@PyrlsApp
Pyrls
11 days
FDA Approves KERENDIA (finerenone) for Heart Failure With Left Ventricular Ejection Fraction ≥40%
Tweet media one
0
3
26
@PyrlsApp
Pyrls
16 days
NAPLEX Formula and Calculation Reference Sheet 🔮 . Free PDF download available in your Pyrls app or at
Tweet media one
0
0
3
@PyrlsApp
Pyrls
19 days
FDA Approves EKTERLY (sebetralstat) for the Treatment of Hereditary Angioedema
Tweet media one
0
2
10
@PyrlsApp
Pyrls
23 days
FDA Approves LYNOZYFIC (linvoseltamab-gcpt) for Relapsed or Refractory Multiple Myeloma
Tweet media one
0
3
11
@PyrlsApp
Pyrls
25 days
FDA Requires Expanded Labeling Regarding Weight Loss Risk in Children Ages <6 Years Taking ER Stimulants for ADHD
Tweet media one
0
0
6
@PyrlsApp
Pyrls
1 month
Listen to the new CEimpact GameChangers podcast on optimizing asthma care! We were thrilled to partner with CEimpact on this episode and are excited about our continued collaboration!
Tweet media one
0
1
5
@PyrlsApp
Pyrls
1 month
FDA Investigating Fatal Acute Liver Failure Deaths in Certain Duchenne Muscular Dystrophy Patients Treated with ELEVIDYS (Delandistrogene Moxeparvovec-rokl)
Tweet media one
0
0
0
@PyrlsApp
Pyrls
1 month
FDA Approves YEZTUGO (Lenacapavir) for HIV PrEP
Tweet media one
0
3
22
@PyrlsApp
Pyrls
1 month
FDA Approves MAVYRET (Glecaprevir/Pibrentasvir) for the Treatment of Acute HCV infection
Tweet media one
0
1
6
@PyrlsApp
Pyrls
2 months
FDA Approves ENFLONSIA (clesrovimab-cfor) for Prevention of RSV Lower Respiratory Tract Disease in Infants
Tweet media one
0
0
1
@PyrlsApp
Pyrls
2 months
FDA Approves WIDAPLIK (Telmisartan, Amlodipine, Indapamide) for the Treatment of Hypertension
Tweet media one
1
6
34
@PyrlsApp
Pyrls
2 months
FDA Approves TRYPTYR (Ophthalmic Acoltremon) for the Treatment of Dry Eye Disease
Tweet media one
0
1
9
@PyrlsApp
Pyrls
2 months
FDA Approves NUCALA (Mepolizumab) for the Treatment of COPD in Adults
Tweet media one
0
4
14
@PyrlsApp
Pyrls
2 months
FDA Warns of Rare & Severe Itching After Stopping Long-Term Use of Cetirizine or Levocetirizine
Tweet media one
0
1
9
@PyrlsApp
Pyrls
2 months
FDA Approves the First At-Home Self-Collection Device (TEAL WAND) for Cervical Cancer Screening
Tweet media one
1
0
5
@PyrlsApp
Pyrls
3 months
2025 CDC nPEP Recommendations Published
Tweet media one
0
4
10